Ferric carboxymaltose effects on restless legs syndrome and on brain iron in patients with iron deficiency anemia.

Sleep medicine(2023)

引用 0|浏览1
暂无评分
摘要
This study demonstrates that 1500 mg FCM effectively treats RLS symptoms in IDA patients over six weeks, with MRI measurements of improved brain iron content serving as a potential biomarker for RLS patients.
更多
查看译文
关键词
ferric carboxymaltose effects,iron deficiency anemia,brain iron,restless legs syndrome
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要